Tailoring Treatment for Optimal Outcomes in Patients With AAV
Bernhard Hellmich, MD
Andreas Kronbichler, MD
Patient Case Study: Obesity
Renato D. Lopes, MD, MHS, PhD
Valeria Caso, MD, PhD
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
Elevating Care for Patients With Severe Renal Disease in AAV
Silke R. Brix, MD, MRCP, SCPR
Don't Miss It! Rapid & Accurate AAV Diagnosis
Setting the Stage of Real-World Data vs RCT
Trade off: Ischemic/Thrombotic vs Bleeding
Implementing the SOC Induction Therapies in AAV
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
Alexander T. Cohen, MD, MBBS
Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
Mikhail Kosiborod, MD
Stephen J. Greene, MD, FACC, FHFSA
AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care
Mazen Hanna, MD
LDL-C Management Trends in ASCVD Patients
Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
John Russell, MD
Noel Dasgupta, MD, FACC
Sami Khella, MD
Bempedoic acid reduces adverse limb events in patients with PAD
Marc Bonaca, MD
No benefit of routine spironolactone post-MI
Sanjit Jolly, MD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.